Market Cap

Virbac SA Market Capitalization:

€2.00 Billion

EUR as of Jan. 1, 2023

US$2.13 Billion

business Virbac SA Company Profile

Virbac SA Main Stock Listing

show_chart Euronext: VIRP

Market Capitalization History of Virbac SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Johnson & Johnson $461.85 B
Lilly $347.61 B
Pfizer $287.63 B
AbbVie $285.80 B
Merck $281.30 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of Virbac SA market cap

Date Market Cap YoY Change
Jan. 1, 2023 €2.00 B -33.47%
Jan. 1, 2022 €3.00 B 65.73%
Jan. 1, 2021 €1.81 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Virbac SA Categories

France languages Healthcare languages Drug Manufacturers—General
France Healthcare France Drug Manufacturers—General

Stocks & Indices

Virbac SA has the following listings and related stock indices.


Stock: Euronext: VIRP

Stock: FSX: V16

Stock: OTC: VRBCF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.